https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00520-4/fulltext
0
0
9/5/22 at 11:18pm
Organization
The Lancet
Authors
The treatment landscape for metastatic, hormone-sensitive prostate cancer has transformed
in recent years, with the emphasis now on early treatment intensification through
a combination approach to systemic therapy. Now that the addition of a second-generatio…
Create an account
or login to join the discussion